Global Acute Ischemic Stroke Therapeutics Market 2017-2021

Publisher Name :
Date: 09-Aug-2017
No. of pages: 84
Inquire Before Buying

About Acute Ischemic Stroke Therapeutics

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.

The analysts forecast global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global acute ischemic stroke therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs from various drug classes.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

This report, Global Acute Ischemic Stroke Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bayer

Boehringer Ingelheim

F. Hoffmann-La Roche

Sanofi

Other prominent vendors

Biogen

Daiichi Sankyo

Pfizer

Market driver

Increasing adoption of NOACs

For a full, detailed list, view our report

Market challenge

Unmet needs for anticoagulant reversal agents

For a full, detailed list, view our report

Market trend

TBI, a value-addition in AIS research

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

Global Acute Ischemic Stroke Therapeutics Market 2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Acute ischemic stroke (AIS): An overview
Ischemia
IHD
Stroke
AIS
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Pipeline landscape
PART 08: Market segmentation by drug-class
Thrombolytic therapeutics
Antihypertensive therapeutics
Antiplatelet therapeutics
Anticoagulants
Others
PART 09: Geographical segmentation
Market overview based on geography
AIS therapeutics market in Americas
AIS therapeutics market in EMEA
AIS therapeutics market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
Market drivers
Market challenges
PART 12: Market trends
TBI, a value-addition in AIS research
Advent of genomic medicine
PART 13: Vendor landscape
Competitive scenario
Key news
PART 14: Key vendor analysis
Bayer
Boehringer Ingelheim
F. Hoffmann-La Roche
Sanofi
Other prominent vendors
PART 15: Appendix
List of abbreviations

List of Exhibits
Exhibit 01: Symptoms of AIS
Exhibit 02: Global AIS therapeutics market: Snapshot
Exhibit 03: Global AIS therapeutics market 2016-2021 ($ millions)
Exhibit 04: Mechanism of action of alteplase
Exhibit 05: Global AIS therapeutics market: Opportunity analysis
Exhibit 06: Five forces analysis
Exhibit 07: Pipeline snapshot
Exhibit 08: Key clinical trials
Exhibit 09: Global AIS therapeutics market segmentation by drug-class
Exhibit 10: Global AIS therapeutics market share by drug-class 2016
Exhibit 11: Global AIS thrombolytic therapeutics market 2016-2021 ($ millions)
Exhibit 12: Global AIS antihypertensive therapeutics market 2016-2021 ($ millions)
Exhibit 13: Global AIS antiplatelet therapeutics market 2016-2021 ($ millions)
Exhibit 14: Global AIS anticoagulant therapeutics market 2016-2021 ($ millions)
Exhibit 15: Global AIS therapeutics market share by geography 2016 and 2021
Exhibit 16: Global AIS therapeutics market by geography 2016-2021 ($ millions)
Exhibit 17: Global AIS therapeutics market by geography 2016-2021 (% share)
Exhibit 18: AIS therapeutics market scenario in different geographies
Exhibit 19: Market scenario in Americas
Exhibit 20: Stroke scenario in US: An overview
Exhibit 21: AIS therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 22: Market scenario in EMEA
Exhibit 23: AIS therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 24: Market scenario in APAC
Exhibit 25: AIS therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 26: Prevalence of stroke in US
Exhibit 27: ACTIVASE regional sales 2015 and 2016
Exhibit 28: Prevalence of obesity among US adults in 2015
Exhibit 29: Competitive structure analysis of global AIS therapeutics market 2016
Exhibit 30: Bayer: Key highlights
Exhibit 31: Bayer: Strength assessment
Exhibit 32: Bayer: Strategy assessment
Exhibit 33: Bayer: Opportunity assessment
Exhibit 34: Boehringer Ingelheim: Key highlights
Exhibit 35: Boehringer Ingelheim: Strength assessment
Exhibit 36: Boehringer Ingelheim: Strategy assessment
Exhibit 37: Boehringer Ingelheim: Opportunity assessment
Exhibit 38: F. Hoffmann-La Roche: Key highlights
Exhibit 39: F. Hoffmann-La Roche: Strength assessment
Exhibit 40: F. Hoffmann-La Roche: Strategy assessment
Exhibit 41: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 42: Sanofi: Key highlights
Exhibit 43: Sanofi: Strength assessment
Exhibit 44: Sanofi: Strategy assessment
Exhibit 45: Sanofi: Opportunity assessment
  • Sarcopenia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 71
    Sarcopenia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Pipeline Review, H2 2018, provides an overview of the Sarcopenia (Musculoskeletal Disorders) pipeline landscape. Sarcopenia is an aging-associated condition which is characterized by loss of muscle mass, strength and function. Symptoms include weakness, loss of endurance and poor balance. Causes of sarcopenia include......
  • Degenerative Disc Disease - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 72
    Degenerative Disc Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Pipeline Review, H2 2018, provides an overview of the Degenerative Disc Disease (Musculoskeletal Disorders) pipeline landscape. Degenerative disc disease is refers to degeneration of intervertebral discs of the spinal column. The main symptom of degenerative disc disease is pain, which o......
  • Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 319
    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018, provides an overview of the Systemic Sclerosis (Scleroderma) (Immunology) pipeline landscape. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pains, joint......
  • Myasthenia Gravis - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 133
    Myasthenia Gravis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Pipeline Review, H2 2018, provides an overview of the Myasthenia Gravis (Immunology) pipeline landscape. Myasthenia gravis is autoimmune neuromuscular disease characterized by weakness and rapid fatigue of any of the muscles under voluntary control. Symptoms include drooping of one or both eyelids, dipl......
  • Birch Pollen Allergy - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 45
    Birch Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape. Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingli......
  • House Dust Mite Allergy - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 51
    House Dust Mite Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H2 2018, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. As......
  • Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment, Number of Patients Treated, Specifications & Company Analysis - Global Forecast to 2024
    Published: 12-Jul-2018        Price: US 2390 Onwards        Pages: 429
    The rise in popularity of proton therapy is continuing across the globe. It is estimated that more than 165,000 patients suffering from a variety of cancers, such as prostate cancer, brain tumors, etc. have already been successfully treated using this method. In fact, the proton therapy market is on track to become a multibillion-dollar industry by 2024. The number of proton therapy centers is increasing globally. Still, industry experts believe that players will miss out on a majority of can......
  • Global and United States Infantile Spasms Therapeutics Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 111
    Summary An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending for......
  • 2013-2023 Global Infrared light therapy device Industry Report
    Published: 02-Jul-2018        Price: US 4000 Onwards        Pages: 150
    The global market size of Infrared Light Therapy Device is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This repor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs